Leenders MW, Nijkamp MW, Rinkes IHB. Mouse models in liver cancer research: A review of current literature. World J Gastroenterol 2008; 14(45): 6915-6923 [PMID: 19058325 DOI: 10.3748/wjg.14.6915]
Corresponding Author of This Article
Dr. Inne HM Borel Rinkes, MD, PhD, Professor, Department of Surgery, University Medical Center Utrecht, PO box 85500, Utrecht GA 3508, The Netherlands. i.h.m.borelrinkes@umcutrecht.nl
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2008; 14(45): 6915-6923 Published online Dec 7, 2008. doi: 10.3748/wjg.14.6915
Mouse models in liver cancer research: A review of current literature
Martijn WH Leenders, Maarten W Nijkamp, Inne HM Borel Rinkes
Martijn WH Leenders, Maarten W Nijkamp, Inne HM Borel Rinkes, Department of Surgery, University Medical Center Utrecht, Utrecht GA 3508, The Netherlands
Author contributions: Leenders MWH and Nijkamp MW contributed equally to this work; Leenders MWH and Nijkamp MW performed the literature search and wrote the article; Borel Rinkes IHM is chief investigator, guided the research work and revised the article.
Correspondence to: Dr. Inne HM Borel Rinkes, MD, PhD, Professor, Department of Surgery, University Medical Center Utrecht, PO box 85500, Utrecht GA 3508, The Netherlands. i.h.m.borelrinkes@umcutrecht.nl
Telephone: +31-88-7558074 Fax: +31-30-2541944
Received: May 26, 2008 Revised: August 7, 2008 Accepted: August 14, 2008 Published online: December 7, 2008
Abstract
Primary liver cancer remains one of the most lethal malignancies worldwide. Due to differences in prevalence of etiological factors the incidence of primary liver cancer varies among the world, with a peak in East-Asia. As this disease is still lethal in most of the cases, research has to be done to improve our understanding of the disease, offering insights for possible treatment options. For this purpose, animal models are widely used, especially mouse models. In this review, we describe the different types of mouse models used in liver cancer research, with emphasis on genetically engineered mice used in this field. We focus on hepatocellular carcinoma (HCC), as this is by far the most common type of primary liver cancer, accounting for 70%-85% of cases.